Nicolas Pierre

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Disease Activity

Top Venues

Journal of Crohn's & colitis

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Nicolas Pierre, Vân Anh Huynh-Thu, Dominique Baiwir, Gabriel Mazzucchelli, Maximilien Fléron, Lisette Trzpiot, Gauthier Eppe, Edwin De Pauw, David Laharie, Jack Satsangi, Peter Bossuyt, Lucine Vuitton, Sophie Vieujean, Jean Frederic Colombel, Marie-Alice Meuwis, Edouard Louis, null null
External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn's disease stopping infliximab. Gut (2024)
Nicolas Pierre, Sophie Vieujean, Laurent Peyrin-Biroulet, Marie-Alice Meuwis, Edouard Louis
Defining biological remission in Crohn's disease: interest, challenges and future directions. Journal of Crohn's & colitis (2023)
Nicolas Pierre, Vân Anh Huynh-Thu, Thomas Marichal, Matthieu Allez, Yoram Bouhnik, David Laharie, Arnaud Bourreille, Jean-Frédéric Colombel, Marie-Alice Meuwis, Edouard Louis, null null
Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn's disease stopping infliximab: when the remission state hides different types of residual disease activity. Gut (2022)
Nicolas Pierre, Catherine Salée, Sophie Vieujean, Emeline Bequet, Angela-Maria Merli, Britta Siegmund, Marie-Alice Meuwis, Edouard Louis
Review article: distinctions between ileal and colonic Crohn's disease: from physiology to pathology. Alimentary pharmacology & therapeutics 54 (6) (2021)
Nicolas Pierre, Dominique Baiwir, Vân Anh Huynh-Thu, Gabriel Mazzucchelli, Nicolas Smargiasso, Edwin De Pauw, Yoram Bouhnik, David Laharie, Jean-Frédéric Colombel, Marie-Alice Meuwis, Edouard Louis, null null
Discovery of biomarker candidates associated with the risk of short-term and mid/long-term relapse after infliximab withdrawal in Crohn's patients: a proteomics-based study. Gut (2020)